Sleep Number Corp ((SNBR)) has held its Q4 earnings call. Read on for the main highlights of the call.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sleep Number’s latest earnings call painted a picture of a company in the midst of a credible turnaround but still wrestling with real pressures. Management highlighted better‑than‑expected profitability, strong traction from a key product launch, and major cost cuts, yet also acknowledged weak sales, margin drag from clearance activity, and ongoing liquidity and capital‑structure concerns. Overall, the tone was cautiously optimistic rather than celebratory.
EBITDA Beat Signals Early Payoff from Turnaround
Sleep Number reported full‑year adjusted EBITDA of $78 million, topping its prior guidance of $70 million and suggesting operational fixes are gaining traction. Pro forma adjusted EBITDA margin reached roughly 9%, about 200 basis points higher than last year, giving investors some comfort that profitability is moving in the right direction despite revenue pressure.
New Comfort Mode Mattress Delivers Strong Early Results
The company’s new 10‑inch Comfort mode mattress, launched in January, is dramatically outpacing expectations, selling 3.5 times plan through February. Management said Comfort mode is also nearly twice the combined sales of the three C Series beds it replaces and carries roughly a 10‑point gross margin lift, making it a key lever for both growth and profitability.
Deep Cost Cuts Underpin Margin Recovery Effort
Sleep Number has already executed about $185 million of annualized cost savings that will benefit 2025, reflecting an aggressive restructuring of its expense base. On top of that, it has identified another $50 million of annualized fixed cost reductions targeted for 2026, which management expects will further support margins and reduce cash burn as the reset progresses.
Sales Hold to Guidance Despite Lower Marketing
Full‑year net sales came in at $1.41 billion, in line with company guidance even as advertising budgets were trimmed and store traffic weakened. The ability to hit the top‑line target in a softer demand environment gives some credibility to management’s claims that it can balance tighter spending with maintaining brand presence and revenue.
Marketing Funnel and Brand Health Show Momentum
Despite lower marketing dollars, the company reported that key funnel metrics improved through 2025, with more consumers moving from awareness to consideration. Brand consideration among premium mattress shoppers rose 10% and reached the highest level in the premium category, with six‑year highs on perceived value, quality, comfort, and individualized comfort, supporting future demand.
Cash Usage and Liquidity Better Than Feared
Sleep Number used $18 million of cash in 2025 versus guidance for a $50 million outflow, reflecting tighter working‑capital management and cost control. Year‑end total liquidity, including cash and revolver availability, stood at $58 million, comfortably above the amended covenant floor of $30 million, and the company remained in compliance with its credit agreements.
Rapid Product Reset Shrinks Lineup and Speeds Launches
Management emphasized the speed of its product overhaul, completing a large‑scale reset in about 10 months for work that typically takes more than two years. The lineup has been simplified from 12 to 7 mattresses, with new SKUs rolling out from March 23 and most store floors expected to be updated by mid‑April, which should streamline operations and improve sell‑through.
Revenue Declines Continue to Weigh on the Story
Despite operational wins, the top line remains under pressure, with fourth‑quarter net sales of $347 million down 8% year over year. For the full year, net sales declined 16% versus the prior year, although management noted the comparison was inflated by a 53rd week last year that contributed roughly 660 basis points to the decline.
One‑Time Inventory Charge Hits Q4 Gross Margin
Fourth‑quarter gross profit margin fell to 55.6%, a 430‑basis‑point decline from the prior year, largely due to a $9.6 million nonrecurring inventory obsolescence charge tied to the product reset. Excluding that charge, adjusted Q4 gross margin would have been 58.4%, suggesting underlying profitability is healthier than the headline number implies.
Capital Structure and Liquidity Remain Key Risks
Even with better‑than‑expected cash use, management acknowledged ongoing pressure on liquidity and debt covenants stemming from industry softness and clearance‑driven volatility. The company has hired Guggenheim Securities to help evaluate refinancing and other capital‑structure options, a clear signal that shoring up the balance sheet is a top strategic priority.
Store Network Disruption Adds to Near‑Term Headwinds
Operational disruptions also weighed on performance, as 236 stores were closed at least one day in January due to severe weather, hurting early‑year sales. Over the full year, the store base shrank by 40 locations to 600, reflecting both deliberate footprint rationalization and the logistical demands of rolling out the new product lineup.
Inventory Clearance Pressures Q1 Margins
As part of the reset, Sleep Number is clearing legacy SKUs, a process the company says is creating expected margin pressure in the first quarter. Management described an inventory “hangover” extending into March and acknowledged some unexpected clearance impacts, implying that near‑term gross margins will remain choppy before the new assortment fully takes hold.
Free Cash Flow Improves Versus Plan but Trails Last Year
The company posted full‑year free cash flow usage of $18 million, about $30 million better than its internal plan and reflective of improving discipline. However, free cash flow was still $21 million worse than the prior year, driven mainly by weaker sales and one‑time cash restructuring charges, underscoring that the turnaround is not yet complete.
Limited Near‑Term Visibility Without Formal 2026 Guidance
Given the scale of the product reset and early‑year softness, management chose not to issue formal 2026 guidance, leaving investors with less precise near‑term visibility. Instead, executives pointed to directional expectations for improvement, asking the market to focus on trend lines rather than specific quarterly targets as the new strategy plays out.
Management Sets Directional Targets for a 2026 Recovery
Looking ahead, Sleep Number expects first‑quarter net sales to fall in the high‑teens percentage but to improve significantly in the second quarter, with double‑digit sales growth targeted for the back half of the year. Management is aiming for full‑year 2026 adjusted EBITDA growth in the high‑teens to mid‑20s percent versus 2025’s $78 million, flat overall marketing spend rephased toward Q2 and later quarters, and a return to positive free cash flow as cost cuts and the new product lineup gain traction.
The earnings call portrayed a company that has moved quickly to fix its operations and product offering, but is still working through the financial aftershocks of a tough year. Strong early results from Comfort mode, sizable cost savings, and better‑than‑expected cash use support the turnaround case, while weak sales, margin volatility, and capital‑structure risk keep the story firmly in “show‑me” territory for investors.